Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Levetiracetam-induced diffuse interstitial lung disease.

Scott D Newsome1, Lanny Y Xue, Timothy Jennings

  • 1Department of Neurology, Albany Medical Center, Albany, NY 12208, USA. newsoms@mail.amc.edu

Journal of Child Neurology
|August 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Unsupervised Approach for Artifact Severity Scoring in Multi-Contrast MR Images.

Proceedings of machine learning research·2026
Same author

Association of epiretinal membranes with disability in people with multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Influence of OSCAR-IB criteria on test-retest reliability of Spectralis SD-OCT retinal thickness measurements in people with Multiple Sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Functional cycling ergometry with or without electrical stimulation in individuals with secondary progressive multiple sclerosis: A randomized controlled trial.

Multiple sclerosis and related disorders·2026
Same author

Understanding stiff-person syndrome: Epidemiological trends, diagnostic challenges, and treatment advances.

Journal of neuroimmunology·2026
Same author

UNISELF: A unified network with instance normalization and self-ensembled lesion fusion for multiple sclerosis lesion segmentation.

Medical image analysis·2026

This study details the first reported case of diffuse interstitial lung disease caused by levetiracetam. Discontinuation of the anti-epileptic drug levetiracetam led to clinical improvement in a pediatric patient.

Area of Science:

  • Pediatric Pulmonology
  • Neurology
  • Clinical Pharmacology

Background:

  • Levetiracetam is a widely used anti-epileptic drug.
  • Diffuse interstitial lung disease is a serious pulmonary condition.
  • Aspiration pneumonia is common in children with neurological impairments.

Observation:

  • A 9-year-old girl with epilepsy and cerebral palsy presented with refractory aspiration pneumonia.
  • Her levetiracetam dosage was recently increased.
  • Lung biopsy revealed a diffuse interstitial lung process.

Findings:

  • Levetiracetam was identified as the likely cause of drug-induced interstitial pneumonitis.
  • The patient's condition improved after levetiracetam withdrawal and steroid treatment.

Related Experiment Videos

Implications:

  • This case highlights a rare but significant adverse effect of levetiracetam.
  • Clinicians should consider levetiracetam-induced lung disease in patients with unexplained pulmonary symptoms.
  • Further research is warranted to understand the mechanism of levetiracetam-induced lung injury.